Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer

We investigated the activity of irinotecan given with a more convenient modified bimonthly de Gramont regimen of bolus and infusional 5-fluorouracil [IrMdG] in advanced or metastatic colorectal cancer in the first and second line setting. Irinotecan 180 mg m(−2) was infused over 90 min. L-folinic ac...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Leonard, P, Seymour, M T, James, R, Hochhauser, D, Ledermann, J A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2002
Pynciau:
Clinical
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2408897/
https://ncbi.nlm.nih.gov/pubmed/12439708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600641
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg